Participants, methods, and results
We studied children aged 7.5 years participating in the Avon Longitudinal Study of Parents and Children (ALSPAC), a population based birth cohort study established in 1990. 3 Two stage screening included a sensitive initial radioimmunoassay for antibodies to tissue transglutaminase (endomysial antigen) with further testing of positive samples for IgA-EMA by indirect immunofluorescence. 4 Children with tTG antibodies below the 97.5th centile were defined as antibody negative. Height, weight, and haemoglobin levels were measured at dedicated study clinics. Details of gastrointestinal symptoms and special diets were collected by routine questionnaire at age 6.75 years.
Of 5470 children tested, 54 tested positive for IgA-EMA (1.0%; 95% confidence interval 0.8 to 1.4). IgA-EMA were more common in girls (odds ratio 2.12; 1.20 to 3.75). IgA-EMA positive children were shorter and weighed less than those who tested negative for tTG antibody (P < 0.0001 for all comparisons). 4324 (79%) returned questionnaires, and 50% of IgA-EMA positive children reported diarrhoea compared with 34% of tTG antibody negative (odds ratio 1.96; 1.06 to 3.59). Only one IgA-EMA positive child had consulted a doctor about diarrhoea. There was no overall difference in the number of episodes of diarrhoea. Vomiting, abdominal pain, and constipation were not associated with EMA, but more IgA-EMA positive children reported multiple symptoms. Only four children (0.09%; 0.1 to 0.32) were on a gluten-free diet. Of these, three were tTG antibody negative, consistent with effective treatment, and one was IgA-EMA positive (table) .
Comment
At age 7, 1% of children were IgA-EMA positive and likely therefore to have subclinical coeliac disease, though less than 0.1% were reported to be on a glutenfree diet. The prevalence of coeliac disease in these children is therefore comparable to that in UK adults. 5 The benefit of early diagnosis of subclinical coeliac disease remains unproven, but long term follow up of this cohort may help to resolve this. If screening is worth while, it should be started in childhood.
Since ALSPAC is an observational study based on analysis of anonymous samples, 3 confirmatory biopsy was not possible. IgA-EMA have however repeatedly been shown to have high sensitivity and specificity for coeliac disease, and in a recent general population study the combination of IgA-EMA and tTG antibodies that we used was associated with diagnostic histological changes in 83% of those subsequently biopsied, with abnormal intestinal / T-lymphocyte density in a further 12%. 2 Our strategy may even miss some affected children, as individuals with high levels of tTG antibodies without IgA-EMA may have coeliac disease. 2 Reported clinical features were similar to those in adults with coeliac disease identified by screening. Gastrointestinal symptoms were not prominent, and the excess in girls mirrors that seen in affected adults. The most striking observation was that children with IgA-EMA were shorter by more than 0.76 standard deviation scores and lighter by 0.54 standard deviation scores than antibody negative children matched for date and place of birth. This equates to about 9 months' growth and weight gain in an average child around this age. These features were independent of gastrointestinal symptoms and anaemia and presumably unrelated to malabsorption. Occult coeliac disease seems to start in childhood, even in those who are subsequently diagnosed as adults. The search for the trigger resulting in the breakdown of immune tolerance to gluten therefore needs to focus on infancy and intrauterine life.
We thank the children and their families taking part in the study for their continuing support and the midwives for their cooperation and help in recruitment. The ALSPAC study team comprised interviewers, computer technicians, clerical workers, research scientists, volunteers, and managers who continue to make the study possible. Use of tobacco products as dentifrice among adolescents in India: questionnaire study
In India legislation prohibits the use of tobacco as an ingredient in dental care products.
1 Such products, in the form of powder or paste, are applied most commonly with the index finger to teeth and gums. Various tobacco products are used as dentifrice in different parts of India. 2 3 We are not aware of any reports covering such a use of tobacco products (in contrast to chewing and smoking) especially among adolescents. 4 5 
Participants, methods, and results
The global youth tobacco survey focuses on school students aged 13-15 and uses standardised methods. 4 In India the survey is being conducted independently in each state. We report on the prevalence of the use of tobacco products as dentifrice in 14 states listed in the table, with sample sizes ranging from 2067 to 5245 students.
We selected a two stage probability sample of students in grade 8-10 (which corresponds to 13-15 years in age) in each state and conducted a survey among students with an anonymous, self administered, close ended questionnaire. Participants were asked to include a maximum of five products, which could differ from state to state. A pilot tested questionnaire for India contained a specific question on application of tobacco products (in addition to chewing), and a positive response identified the use of a tobacco product as dentifrice. We defined current use as use within 30 days preceding the survey.
The overall response rate was over 80% except in Bihar (70%) and Maharashtra (79%). The proportion of boys was between 50% and 55% in the different states.
The use of tobacco products as dentrifice varied from 6% (Goa) to 68% (Bihar). The prevalence among boys was notably higher than among girls in Orissa and Uttaranchal, marginally higher in nine states, and marginally lower in three states. Of the specific products, tobacco toothpaste (creamy snuff) and tooth powder (lal dant manjan) were common in all states (table) . Gul (a pyrolysed tobacco product) was used in eight states. Other dentifrice products containing tobacco were: mishri (roasted and powdered tobacco) and dry snuff (bajjar or tapkir) in Goa and Maharashtra; gudakhu (paste of tobacco and molasses) in Bihar, Orissa, Uttar Pradesh, and Uttaranchal; and tobacco water (tuibur or hidakphu, manufactured by passing tobacco smoke through water) in Manipur, Mizoram, Sikkim, and Tripura. It is used for gargling, not drinking.
Comment
Many students in India use tobacco products as dentifrice. Differences between the sexes were minimal and similar to those reported globally. 5 In India the misconception is widespread that tobacco is good for the teeth. In a study reported from Ernakulam district in Kerala 92% (3013) 
